Dietary Fat and Endothelial Function in Type 1 Diabetes
Influence Of Extra Virgin Olive Oil and Butter on Endothelial Function in Type 1 Diabetes
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of the add-on of extra vergin olive oil or butter to a high glycemic index meal on endothelial function in subjects with type 1 Diabetes and healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2019
CompletedFirst Submitted
Initial submission to the registry
March 12, 2021
CompletedFirst Posted
Study publicly available on registry
March 24, 2021
CompletedMarch 24, 2021
March 1, 2021
1.7 years
March 12, 2021
March 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Endothelial function from pre meal to post meal period
Flow mediated dilation technique by ultrasound
before meal, 1 hour, 3 hour, 5 hour after meal
Secondary Outcomes (2)
Serum glucose
before meal, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour after meal
Gastric emptying rate
before meal, 15, 90, 120, 180, 240, 300 minutes after meal
Study Arms (2)
EVOO-Butter
EXPERIMENTALAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with EVOO and the second with butter.
Butter-EVOO
EXPERIMENTALAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with Butter and the second with EVOO
Interventions
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with EVOO
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with butter
Eligibility Criteria
You may qualify if:
- age ≥ 18 years,
- diagnosis of type 1 diabetes since at least 1 year,
- HbA1c \<8.5% (69 mmol/mol),
- stable insulin therapy for at least 3 months before the enrolment into the study
You may not qualify if:
- pregnancy, celiac disease, history of cardiovascular diseases, hypertension, hyperlipidemia, retinopathy, nephropathy, neuropathy, and ongoing treatment with vasoactive drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Magna Graecia
Catanzaro, 88100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 12, 2021
First Posted
March 24, 2021
Study Start
February 12, 2018
Primary Completion
October 16, 2019
Study Completion
October 16, 2019
Last Updated
March 24, 2021
Record last verified: 2021-03